Robbins LLP Reminds Investors of the Pending Class Action Against Cassava Sciences, Inc. and Urges SAVA Stockholders to Contact the Firm for Information
January 06, 2025 20:26 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that Cassava Sciences, Inc. (SAVA) Misled Investors Regarding its Lead Drug Candidate
Robbins LLP Reminds Investors of the Cassava Sciences, Inc. (SAVA) Class Action and Urges Investors with Large Losses to Contact the Firm for Information
January 02, 2025 15:34 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that Cassava Sciences, Inc. (SAVA) Misled Investors Regarding its Lead Drug Candidate
Cassava Sciences, Inc. Stockholder Alert: Robbins LLP Reminds Investors of the SAVA Class Action
December 19, 2024 20:09 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that Cassava Sciences, Inc. (SAVA) Misled Investors Regarding its Lead Drug Candidate